Jazmin Florio

1.0k total citations
22 papers, 409 citations indexed

About

Jazmin Florio is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Jazmin Florio has authored 22 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 8 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Jazmin Florio's work include Alzheimer's disease research and treatments (10 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Jazmin Florio is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Jazmin Florio collaborates with scholars based in United States, Austria and Jordan. Jazmin Florio's co-authors include Eliezer Masliah, Edward Rockenstein, Robert A. Rissman, Michael Mante, Anthony Adame, Brian Spencer, Cassia Overk, Chengbiao Wu, Ivy Trinh and Changyoun Kim and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Jazmin Florio

19 papers receiving 401 citations

Peers

Jazmin Florio
Niko-Petteri Nykänen United States
Hazel Hall‐Roberts United Kingdom
Verena May Germany
Milena Cioroch United Kingdom
Niko-Petteri Nykänen United States
Jazmin Florio
Citations per year, relative to Jazmin Florio Jazmin Florio (= 1×) peers Niko-Petteri Nykänen

Countries citing papers authored by Jazmin Florio

Since Specialization
Citations

This map shows the geographic impact of Jazmin Florio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jazmin Florio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jazmin Florio more than expected).

Fields of papers citing papers by Jazmin Florio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jazmin Florio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jazmin Florio. The network helps show where Jazmin Florio may publish in the future.

Co-authorship network of co-authors of Jazmin Florio

This figure shows the co-authorship network connecting the top 25 collaborators of Jazmin Florio. A scholar is included among the top collaborators of Jazmin Florio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jazmin Florio. Jazmin Florio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Podvin, Sonia, Jazmin Florio, Brian Spencer, et al.. (2025). Activation of Cytosolic Cathepsin B Activity in the Brain by Traumatic Brain Injury and Inhibition by the Neutral pH Selective Inhibitor Probe Z-Arg-Lys-AOMK. ACS Chemical Neuroscience. 16(7). 1297–1308. 2 indexed citations
2.
Hook, Vivian, Sonia Podvin, Michael C. Yoon, et al.. (2025). Neutral pH-Selective Inhibition of Cytosolic Cathepsin B: A Novel Drug Targeting Strategy for Traumatic Brain Injury and Alzheimer’s Disease. ACS Chemical Biology. 20(8). 1841–1848.
4.
Kulbe, Jacqueline R., K.A. Walter, Michael Mante, et al.. (2024). Cannabis Use and Cannabidiol Modulate HIV-Induced Alterations in TREM2 Expression: Implications for Age-Related Neuropathogenesis. Viruses. 16(10). 1509–1509.
5.
Florio, Jazmin, Michael Mante, Hee Young Kim, et al.. (2024). CSF1R-mediated myeloid cell depletion shifts the ratio of motor cortical excitatory to inhibitory neurons in a multiple system atrophy model. Experimental Neurology. 374. 114706–114706. 2 indexed citations
6.
Castro, Alfredo, Kijung Sung, Ruinan Shen, et al.. (2023). Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy. Neurobiology of Disease. 178. 106010–106010. 6 indexed citations
7.
Florio, Jazmin, Michael Mante, Addison J. Lana, et al.. (2022). CSF1R-Mediated Myeloid Cell Depletion Prolongs Lifespan But Aggravates Distinct Motor Symptoms in a Model of Multiple System Atrophy. Journal of Neuroscience. 42(40). 7673–7688. 8 indexed citations
8.
Ngolab, Jennifer, Suhail Rasool, Kimberly Thomas, et al.. (2021). Mutant three-repeat tau expression initiates retinal ganglion cell death through Caspase-2. Neurobiology of Disease. 152. 105277–105277. 6 indexed citations
9.
Spencer, Brian, Ivy Trinh, Edward Rockenstein, et al.. (2019). Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease. Neurobiology of Disease. 127. 163–177. 35 indexed citations
10.
Mandler, Markus, Edward Rockenstein, Cassia Overk, et al.. (2019). Effects of single and combined immunotherapy approach targeting amyloid β protein and α‐synuclein in a dementia with Lewy bodies–like model. Alzheimer s & Dementia. 15(9). 1133–1148. 18 indexed citations
11.
Chen, Xu‐Qiao, Fang Fang, Jazmin Florio, et al.. (2018). T‐complex protein 1‐ring complex enhances retrograde axonal transport by modulating tau phosphorylation. Traffic. 19(11). 840–853. 21 indexed citations
12.
Spencer, Brian, Sven Brüschweiler, Marco Sealey‐Cardona, et al.. (2018). Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders. Acta Neuropathologica. 136(1). 69–87. 23 indexed citations
13.
Fang, Fang, Wanlin Yang, Jazmin Florio, et al.. (2017). Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson’s disease. Scientific Reports. 7(1). 3868–3868. 68 indexed citations
14.
Rockenstein, Edward, Gary R. Ostroff, Florentina Rus, et al.. (2017). Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies. Journal of Neuroscience. 38(4). 1000–1014. 41 indexed citations
15.
Fields, Jerel Adam, Cassia Overk, Anthony Adame, et al.. (2017). The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. Journal of NeuroVirology. 23(2). 290–303. 15 indexed citations
16.
Spencer, Brian, Paula Desplats, Cassia Overk, et al.. (2016). Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model. Journal of Neuroscience. 36(30). 7971–7984. 44 indexed citations
17.
Overk, Cassia, Edward Rockenstein, Jazmin Florio, Qun Cheng, & Eliezer Masliah. (2015). Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506. Neuroscience. 310. 549–560. 24 indexed citations
18.
Rockenstein, Edward, Paula Desplats, Kiren Ubhi, et al.. (2015). Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease. Stem Cell Research. 15(1). 54–67. 38 indexed citations
19.
Rockenstein, Edward, Paula Desplats, Kiren Ubhi, et al.. (2015). Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease. SHILAP Revista de lepidopterología. 9s2(Suppl 2). 131–40. 6 indexed citations
20.
Rockenstein, Edward, Paula Desplats, Michael Mante, et al.. (2014). P4‐204: NEURO‐PEPTIDE TREATMENT WITH CEREBROLYSIN IMPROVES THE SURVIVAL OF NEURAL STEM CELL GRAFTS IN THE APP TRANSGENIC MODEL OF ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 10(4S_Part_23). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026